Contineum Therapeutics, Inc Class A Common Stock
Price & Volume
Stats
See more52W Range | $8.42-$17.78 |
Market Cap | $503.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.73 |
News
See moreYahoo Finance • 2 days ago
Bristol Myers Stock Tumbles on ‘Confounding’ Trial Results
Yahoo Finance • 19 days ago
J&J and Contineum’s Depression Drug Missed Phase 2 Goal. What Comes Next?
Yahoo Finance • last month
Johnson & Johnson Owns Stakes in 15 Stocks. Here's the Best of the Bunch.
Yahoo Finance • 2 months ago
Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones
About
CEO | Mr. Carmine N. Stengone MBA, MS |
Address | 3565 General Atomics Court, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 51 |